Becker's Healthcare October 15, 2024
Naomi Diaz

The Drug Enforcement Administration is signaling that it will extend flexibilities, enacted during the COVID-19 pandemic, that allows healthcare providers to prescribe specific controlled substances via telehealth, Politico reported Oct. 11.

Seven things to know:

  1. A new rule called “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” was sent to the White House for review on Oct. 10.
  2. According to Politico, it’s not yet known how long the extension will last.
  3. The possible delay means that either Vice President Kamala Harris or former President Donald Trump’s administration will have to address the issue.
  4. This extension would allow healthcare providers to prescribe specific controlled substances via telehealth. This includes stimulant medications for attention-deficit/hyperactivity disorder,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Digital Health, Govt Agencies, Patient / Consumer, Provider, Technology, Telehealth
Related Articles:
'A gap in the literature': Why Ascension aims to diversify telehealth
Teladoc Pays $65 Million to Acquire Catapult Health
Teladoc to acquire virtual care company Catapult Health for $65M
Teladoc Health to acquire Catapult Health in $65 million deal
Culina Health: The Rise Of Telehealth Nutrition

Share This Article